Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q1
добавлен 09.05.2024
KemPharm Мультипликаторы 2011-2024 | KMPH
Мультипликаторы по годам KemPharm
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.5 | -7.5 | -35.6 | -4.0 | -7.6 | -13.9 | -31.3 | -48.1 | -32.5 | - | - | - | - |
P/S |
7.5 | 19.7 | 10.6 | 3.8 | 14.6 | - | - | - | - | - | - | - | - |
EPS |
-1.3 | -0.8 | -2.1 | -3.2 | -0.8 | -3.1 | -3.0 | -1.1 | -7.4 | -10.3 | -2.2 | - | - |
EV (Enterprise Value) |
273 млн | 175 млн | 198 млн | 124 млн | 269 млн | 858 млн | 1.46 млрд | 881 млн | 1.81 млрд | 27.8 млн | 24.7 млн | - | - |
EBITDA per Share |
-1.37 | -1.21 | 0.23 | -1.18 | -0.676 | -3.01 | -2.25 | -2.56 | -3.08 | - | - | - | - |
EV/EBITDA |
16.5 | -53.9 | -13.0 | -15.7 | -43.6 | -23.3 | -77.9 | - | - | - | - | ||
PEG |
0.03 | 0.05 | 1.77 | -12.08 | 0.1 | -2.16 | -0.19 | 0.57 | 0.38 | - | - | - | - |
P/B |
3.3 | 2.7 | 2.4 | -0.8 | -2.5 | -11.8 | -23.6 | -42.5 | -175.8 | - | - | - | - |
P/CF |
-6.1 | -10.7 | 29.2 | -26.2 | -7.9 | -14.4 | -40.9 | -26.1 | -87.2 | - | - | - | - |
ROE % |
-74.44 | -35.64 | -8.42 | 19.21 | 32.93 | 84.83 | 75.43 | 88.34 | 540.10 | - | - | - | - |
ROA % |
-26.72 | -23.21 | -6.44 | -113.84 | -233.39 | -211.12 | -82.71 | -19.46 | -98.10 | - | - | - | - |
ROCE % |
-80.18 | -56.66 | 7.60 | 8.45 | -400.65 | -368.11 | -81.49 | -47.90 | -48.15 | - | - | - | - |
Current Ratio |
1.6 | 2.9 | 22.8 | 0.1 | 1.2 | 2.0 | 4.1 | 11.2 | 6.5 | - | - | - | - |
DSO |
154.9 | 154.6 | 24.6 | 56.6 | 53.0 | - | - | - | - | - | - | - | - |
DIO |
651.4 | 551.6 | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1090.5 | 3392.7 | 149.8 | - | 141.3 | - | - | - | - | - | - | - | - |
Операционный цикл |
806.3 | 706.2 | 24.6 | 56.6 | 53.0 | - | - | - | - | - | - | - | - |
Финансовый цикл |
-284.2 | -2686.5 | -125.2 | 56.6 | -88.3 | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально KemPharm
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.4 | - | -0.4 | -0.15 | -0.38 | - | -0.19 | -0.7 | -0.05 | - | -0.05 | -0.4 | -2.49 | - | -0.68 | 0.21 | -1.92 | - | 0.09 | -0.33 | -0.46 | - | -0.94 | -0.65 | -1.77 | -0.72 | -0.68 | -0.44 | -1.11 | -0.68 | -0.92 | 0.59 | -0.2 | -0.64 | -0.68 | -2.45 | -2.5 | -4.97 | -3 | -1.5 | -0.8 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.45 | - | - | - | -0.37 | - | -0.19 | -0.71 | -0.05 | - | -0.06 | 0.2 | 0.37 | - | -0.23 | 0.69 | -0.08 | - | 0.11 | -0.27 | -0.42 | - | -1.1 | -0.9 | -0.99 | -0.56 | -0.64 | -0.55 | -0.5 | -0.74 | -0.7 | -0.63 | -0.48 | -0.5 | -0.45 | -0.49 | -1.29 | -3.14 | -1.8 | -1.26 | -0.65 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-83.10 | -50.54 | -57.59 | -43.83 | -60.64 | -32.82 | -34.15 | -28.43 | 0.54 | -8.81 | -4.28 | 1.59 | -4.45 | 11.90 | 7.79 | -0.86 | 12.87 | 24.83 | 47.47 | 74.22 | 76.80 | 77.04 | 95.41 | 90.12 | 86.44 | 75.43 | 110.21 | 164.60 | 101.02 | 88.34 | 126.12 | 150.65 | 496.77 | 540.10 | 473.59 | 392.02 | 105.51 | 50.41 | 26.00 | 11.29 | 3.93 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-36.02 | -27.32 | -27.32 | -36.57 | -51.10 | -40.18 | -22.11 | -23.40 | 0.42 | -8.20 | -35.04 | -60.60 | -57.41 | -70.51 | -41.36 | 14.63 | -81.13 | -175.93 | -232.28 | -317.78 | -267.04 | -191.74 | -211.88 | -174.56 | -149.62 | -82.71 | -74.27 | -71.05 | -47.12 | -19.46 | -24.61 | -26.66 | -92.65 | -100.14 | -169.62 | -203.81 | -175.37 | -178.32 | -91.98 | -39.94 | -13.89 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-97.21 | -54.12 | -61.19 | -45.48 | -60.74 | -33.55 | -35.24 | -29.86 | -0.44 | 11.04 | 12.86 | 16.38 | 8.01 | 3.61 | -0.74 | -6.91 | 7.46 | 21.39 | 48.37 | 79.69 | 90.12 | 70.06 | 84.23 | 73.96 | 67.37 | 58.01 | 101.80 | 140.72 | 176.03 | 200.48 | 214.47 | 222.86 | 232.10 | 225.41 | 168.90 | 113.82 | 61.25 | 33.90 | 18.46 | 9.52 | 3.24 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.5 | 1.6 | 1.9 | 2.9 | 3.0 | 3.9 | - | 5.0 | 29.9 | 22.8 | 25.2 | 17.1 | 14.6 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 0.5 | 0.5 | 0.5 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.4 | 0.4 | 0.4 | 0.4 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
342.1 | - | 69.3 | 49.1 | 231.6 | - | 44.8 | 215.5 | 55.8 | - | 81.4 | 50.2 | 51.8 | - | 122.2 | 34.1 | 93.0 | - | 14.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | 2942.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
342.1 | - | 69.3 | 49.1 | 231.6 | - | 44.8 | 215.5 | 55.8 | - | 81.4 | 50.2 | 51.8 | - | 122.2 | 34.1 | 93.0 | - | 14.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
342.1 | - | 69.3 | 49.1 | 231.6 | - | 44.8 | 215.5 | -2887.0 | - | 81.4 | 50.2 | 51.8 | - | 122.2 | 34.1 | 93.0 | - | 14.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD